Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.087 AUD | +4.82% |
|
+6.10% | +12.99% |
Jul. 03 | Immuron Files for Mixed-Shelf Offering; Plans to Raise $2M Through At-The-Market Equity Sale | MT |
Jul. 02 | Immuron Requests Meeting With FDA for Potential Colon Infection Therapy | MT |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
12.61M | - | - | - | - | - | |
40.77B | ||||||
33.21B | ||||||
29.36B | ||||||
15.7B | ||||||
13.08B |
- Stock Market
- Equities
- IMC Stock
- Charts Immuron Limited
- Sector Chart